移动站  | 2017年09月24日 星期日
用户登录

当前位置:首页 >> 师资队伍

基本信息:

姓名: 黄河
职务: 医学院党委书记、副院长
职称: 教授
学历: 博士
专业: 内科学(血液病);干细胞与组织工程
所属院系: 浙医一院
研究方向: 造血干细胞移植临床与基础研究; 血液病临床与基础研究; 干细胞研究与应用
电话: 0571-88208003
信箱: hehuangyu@126.com
个人主页:

个人简介:

黄河,浙江大学求是特聘教授,973首席科学家,主任医师,博士生导师。现任浙江大学医学院党委书记、副院长,浙江大学血液病研究所所长,浙江大学医学院附属第一医院骨髓移植中心主任。任中华医学会血液学分会造血干细胞应用学组副组长,中华骨髓库专家委员会副主任委员,亚太国际骨髓移植组织国际学术委员会常务委员(中国唯一),浙江省医学会血液专业委员会主任委员,浙江省抗癌协会血液淋巴肿瘤专业委员会主任委员等学术职务。1984年起从事血液学、造血干细胞移植和干细胞基础与转化研究,先后于2003年及2015年2次荣获国家科技进步奖二等奖。作为负责人承担973,863,国家自然科学基金重点项目,国家自然科学基金国际合作与交流项目等25项。近10年在国内外学术期刊发表论文200余篇,其中在Blood、Leukemia等SCI杂志发表论文125篇(其中通讯作者论文90篇)。获省部级以上奖项14项,授权发明专利16项。近5年在国际大型会议担任主席、特邀报告和口头报告50余次。作为大会主席分别于2005年和2014年在杭州主办亚太国际骨髓与造血干细胞移植大会。主编人民卫生出版社第一版和第二版全国研究生《血液内科学》教材,参编著作及教材5部。任国际造血干细胞移植领域权威杂志Bone Marrow Transplantation和Biology of Blood and Marrow Transplantation 编委。


研究方向:造血干细胞移植临床与基础研究; 血液病临床与基础研究; 干细胞研究与应用


联系方式:

浙江大学医学院

浙江杭州西湖区余杭塘路866号,310058

电话:+86 571 88208003

传真:+86 571 88208022

电子邮箱:hehuangyu@126.com


现任职务:

浙江大学医学院党委书记、副院长

浙江大学医学院附属第一医院骨髓移植中心主任

浙江大学血液病研究所所长


学习经历:

1979.9-1984.7 浙江医科大学 本科 学士

1987.9-1990.7 浙江医科大学 研究生 硕士

1990.9-1993.7 浙江医科大学 研究生 博士


工作经历:

1984.7-1987.9 浙江省金华市中心医院 住院医师

1993.7-1995.9 浙江大学医学院附属第一医院 助理研究员

1995.9-1997.9 浙江大学医学院附属第一医院 副研究员

1997.4-1997.10 德国基尔大学血液病理所 高级访问学者

1997.9-2000.9 浙江大学医学院附属第一医院血液科 副主任/副主任医师

1997.9-2016.10 浙江大学医学院血液病研究所 副所长

2016.10-至今    浙江大学医学院血液病研究所 所长

2000.9-至今 浙江大学医学院附属第一医院骨髓移植中心 主任/主任医师

2000.9-至今 浙江大学医学院 教授

2005.9-至今 浙江大学医学院 副院长

2012.5-至今 浙江大学医学院 党委书记


学术任职:

中华医学会血液学专业委员会造血干细胞应用学组副组长

中华医学会血液学分会常务委员

中国抗癌协会血液肿瘤专业委员会常务委员会委员

亚太国际骨髓移植组织国际学术委员会常务委员会委员

中华医学会浙江省分会血液专业委员会主任委员

中国抗癌协会浙江省分会血液淋巴肿瘤专业委员会主任委员

中华医学会浙江省分会理事

中国免疫学会浙江省分会常务理事

中华骨髓库专家委员会副主任委员

中国病理生理学会实验血液学专业委员会委员

中国免疫学会血液免疫分会委员

中国生物医学工程学会干细胞工程技术分会委员

国家重点研发计划“干细胞及转化研究”重点专项专家组成员

中国医师协会血液分会常委

海峡两岸医药卫生交流协会血液病学专家委员会副主任委员

美国血液学协会会员

欧洲血液学协会会员

国际慢性粒细胞白血病研究协会委员


杂志编委:

Bone Marrow Transplantation(IF:3.541)

中华医学(英文版)

Journal of Hematology and Oncology

中华内科杂志

中华血液学杂志

白血病˙淋巴瘤

国际输血与血液学杂志

中华移植杂志

实用内科杂志


科技奖励:

异基因造血干细胞移植关键技术创新与推广应用  2015年国家科学技术进步奖二等奖(排名第一)

非亲缘异基因骨髓移植临床研究 2003年国家科学技术进步奖二等奖(排名第一)

异基因造血干细胞移植重要并发症的预警与诊治新技术2013年教育部高等学校科学技术进步奖一等奖(排名第一)

间充质干细胞与组织工程产品的研发与应用 2011浙江省科学技术奖一等奖(排名第一)

慢性粒细胞白血病分子靶向治疗及异基因造血干细胞移植最新策略的的建立与推广  2010浙江省科学技术奖一等奖(排名第一)

慢性粒细胞白血病分子靶向治疗及异基因造血干细胞移植最新策略的的建立与推广  2010浙江省医药卫生科技创新奖一等奖(排名第一)

多发性骨髓瘤危险度分层新模式的建立及应用研究2013年浙江省科学技术奖一等奖(排名第十)

急性移植物抗宿主病防治的基础和临床研究 2008年浙江省科学技术奖三等奖(排名第三)

急性移植物抗宿主病防治的基础和临床研究 2008浙江省医药卫生科技创新奖二等奖(排名第三)

人骨髓间充质干细胞纯化建系及临床试验研究2007年浙江省科学技术奖三等奖(排名第二)

骨髓增生异常综合征发病机理及临床研究 2006年浙江省科学技术奖二等奖(排名第三)

骨髓增生异常综合征发病机理及临床研究 2006年浙江省医药卫生科技创新奖二等奖(排名第三)

人骨髓间充质干细胞特异性单克隆抗体的制备及应用 2006年浙江省医药卫生科技创新奖三等奖(排名第一)

人端粒结合因子(TRF1)的临床与基础研究 2003年浙江省科学技术奖二等奖(排名第一)

人端粒结合因子(TRF1)的临床与基础研究 2003年浙江省医药卫生科技创新奖二等奖(排名第一)

非亲缘异基因骨髓移植临床研究 2002年浙江省科学技术奖一等奖(排名第一)

高三尖杉酯碱致白血病细胞凋亡的信号传导和基因调控的研究及其临床意义 2002年浙江省科学技术奖二等奖(排名第五)

高三尖杉酯碱致白血病细胞凋亡的信号传导和基因调控的研究及其临床意义2002年浙江医药卫生科技创新奖一等奖(排名第五)

非亲缘异基因骨髓移植临床研究 2001年浙江省医药卫生科技创新奖一等奖(排名第一)

脐血CD34+造血干细胞纯化和体外扩增的研究 2001年浙江省医药卫生科技创新奖三等奖(排名第二)

血小板血型基础与临床综合研究 2000年浙江省科学技术进步奖三等奖(排名第四)

血小板血型基础与临床综合研究 1999年浙江省卫生厅科技奖二等奖(排名第四)

人端粒重复序列结合因子的克隆、表达纯化和多抗制备 2000年浙江省卫生厅科技奖二等奖(排名第一)

程控冻存对人单个核细胞IL-1IL-2、TNF影响的机理研究 1999年浙江省科学技术进步奖三等奖(排名第二)

程控冻存对人单个核细胞IL-1IL-2、TNF影响的机理研究 1999年浙江省卫生厅科技奖二等奖(排名第二)


主要承担科研项目:

国家自然科学基金国际(地区)合作与交流项目(81520108002):WAS-iPSCs突变基因通过CRISPR/Cas9靶向修复并向造血细胞定向分化研究(2016-2020)(主持人)

国家重大科学研究计划(2015CB964900):多能干细胞定向分化为造血干细胞的调控机理及功能研究(2015-2019)(主持人)

国家自然科学基金重点项目(81230014):PTPN21基因突变和以NKG2D为核心的免疫网络失衡在急性淋巴细胞白血病异基因造血干细胞移植后复发中的作用与机制研究 (2012-2017) (主持人)

国家高技术研究发展计划(863计划)子课题: 骨髓间充质干细胞新药研发 (2011-2014) (主持人)

国家自然科学基金面上项目:CEBPA单基因多点突变致急性白血病发生及其分子机制研究(2012-2015)(主持人)

卫生部科学研究基金:间充质干细胞体内动员及富集分选平台技术的创建(2011-2013)(主持人)

浙江省重大科技专项重点社会发展项目(2012C13021-1):难治、复发白血病新分子靶标的发现及综合治疗技术的建立(2012-2015)(主持人)

浙江省自然科学基金重点项目:调控ALT相关PML小体形成蛋白质作用网络的研究(2011-2014)(主持人)

2010年度高等学校博士学科点专项科研博导类基金(20100101110121):人iPS细胞体外向红细胞诱导分化及其生物学特性的研究(2011-2013)(主持人)

国家自然科学基金(30871098):PML3蛋白及其SUMO化修饰在ALT永生化细胞中的功能及分子机制的研究(2009-2011)(主持人)

国家自然科学基金(30770919):一个新的中心体蛋白TACP1在细胞有丝分裂中的功能及分子机制研究(2008-2010)(主持人)

浙江省医学重点学科:干细胞与组织工程学(2012-2014)(负责人)

浙江省医学重点学科:医学组织工程学(2008-2010)(负责人)

卫生部行业基金(200802027):血液恶性肿瘤及造血干细胞移植患者侵袭性真菌感染的早期抗原和分子生物学诊断实验研究(2008-2011)(负责人)

浙江省科技厅重大研究计划(2006C13022):基于干细胞技术的组织工程研究和产品开发(2007-2009)(主持人)

国家自然科学基金(30570941):一个新的TRF1 结合蛋白TRF1BP1 的功能及对细胞周期调控机制的研究(2006-2007)(主持人)

卫生部科学研究基金(WKJ2005-2-036):自体造血干细胞联合非清髓异基因造血干细胞移植治疗多发性骨髓瘤临床研究(2005-2007)(主持人)

浙江省自然科学基金(R204232):浙江省自然科学基金青年科技人才培养项目NK细胞抑制性KIR功能修饰对移植物抗宿主病的影响及机理研究-黄河课题组(2005-2007)(主持人)

国家重点基础规划发展项目973项目子课题(2002CB713704):调控细胞增殖与肿瘤细胞转移重要蛋白质作用网络研究(2003—2007)(主持人)

浙江省科技厅重点科研项目(2003C23015):间充质干细胞纯化建系和临床应用(2003-2005)(主持人)

浙江省九五科技攻关重大项目(001103058):非亲缘异基因骨髓移植临床研究(2000-2003)(主持人)

浙江省医药卫生九五攻关重点项目(2000ZD001):预防非亲缘异基因骨髓移植中急性移植物抗宿主病的临床和实验研究(2000-2002)(主持人)

浙江省自然科学基金(399141):急性髓细胞性白血病Tankyrase的表达研究   (2000-2002)(主持人)

国家自然科学基金(39870339):急性髓细胞性白血病与人端粒重复序列结合因子(TRF1)突变和表达的研究(1999-2001)(主持人)

浙江省科技厅(991103181):人端粒重复序列结合因子单抗制备及检测技术(1999-2000)(主持人)


发表论文:

Xiao H, Shi J,Luo Y, Tan Y, He J, Xie W, ZhangL, Wang Y, Liu L, Wu K, Yu X,  Cai Z, Lin M, Ye X, Huang H*. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 117: 5257-5260. 2011. (IF: 9.060)

Hu Y, Cui Q, Gu Y, Sheng L, Wu K, Shi J, Tan Y, Fu H, Liu L, Fu S, Yu X,  Huang H*. Decitabine facilitates the generation and immunosuppressive function of regulatory gammadeltaT cells derived from human peripheral blood mononuclear cells. Leukemia. 27: 1580-1585. 2013.  (IF: 10.164)


Wu K, Wang Y, He Y, Hu Y, Fu H, Sheng L, Wang B, Fu S,  Huang H*. Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.Leukemia. 28(1):206-210. 2014. (IF: 10.164)



He Y, Wu K, Hu Y, Sheng L, Tie R, Wang B, Huang H*. γδ T cell and other immune cells crosstalk in cellular immunity. J Immunol Res. 2014 Mar 6  (Epub ahead of print)



Tan Y, Du K, Luo Y, Shi J, Cao L, Zheng Y, Zheng G, Zhao Y, Ye X, Cai Z, Huang H*. Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Transfusion. 2013 Dec 23 (Epub ahead of print) (IF: 3.526)


Wu K, Zhao Y, He Y, Wang B, Du K, Fu S, Hu K, Zhang L, Liu L, Hu Y, Wang Y,  Huang H*.Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways.Leuk Lymphoma. 55(3):668-676.2014. (IF: 2.301)

Gu Y, Hu Y, Hu K, Liao W, Zheng F, Yu X, Huang H*. Rapamycin together with TGF-β1, IL-2 and IL-15 induces the generation of functional regulatory γδT cells from human peripheral blood mononuclear cells. J Immunol Methods. 402(1-2):82-87. 2014. (IF: 2.225)

Xiao H, Luo Y, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Ye X, Yu X, Cai Z, Lin M, Huang H*. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 49(2):241-247. 2014. (IF: 3.541)

Sun J, Fu S, Zhong W, Huang H*. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells. Oncol Rep.30(6):2785-94. 2013.(IF: 2.297)

Jiang Y, Xie W, Hu K, Sun J, Zhu X, Huang H*. An aggressive form of non-Hodgkin's lymphoma with pleural and abdominal chylous effusions: A case report and review of the literature. Oncol Lett. 6(4):1120-1122. 2013. (IF: 0.237)

Zhu X, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Zhang J, Ye X, Lin M, Cai Z, Huang H*.Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation. Leuk Res . 37(9): 1046-51. 2013. (IF: 2.764)

Sheng L, Fu S, Hu Y, Fu H, Huang H*. Rapid mobilization of fully functional natural killer cells into blood by AMD3100. Transfusion. 53(9):2108-1010. 2013. (IF: 3.526)

Xie W, Zhou D, Hu K, Xiao X, Huang W, He J, Shi J, Luo Y, Zhang J, Lin M, Cai Z, Huang H, Ye X*. Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy. Exp Ther Med. 6(1):109-114. 2013. (IF: 0.344)

Zhao Y, Huang H, Wei G*. Novel agents and biomarkers for acute lymphoid leukemia. J Hematol Oncol. 6:40. 2013. (IF: 4.458)

Zhang L, Zheng W, Wang Y, Wang Y, Huang H*. Human bone marrow mesenchymal stem cells support the derivation and propagation of human induced pluripotent stem cells in culture. Cell Reprogram. 15(3):216-223. 2013. (IF2.744)

Zhou D, Xie W, Hu K, Huang W, Wei G, He J, Shi J, Luo Y, Li L, Zhu J, Zhang J, Lin M, Ye X, Cai Z, Huang H*. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases. Asian Pac J Cancer Prev. 14(2):929-34. 2013. (IF: 1.271)

Du K, Hu Y, Wu K, Huang H*.Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Clin Transplant. 27(2):E91-E100. 2013. (IF: 1.634)

Zheng W, Wang Y, Chang T, Huang H*, Yee JK*. Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells. Gene. 519(1):142-9. 2013. (IF: 2.196)

Xie W, Hu K, Xu F, Zhou D, He J, Shi J, Luo Y, Zhu J, Zhang J, Lin M, Ye X, Huang H, Cai Z*. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Ann Hematol. 92(4): 481-486. 2013. (IF: 2.866) 

Shi J, Meng X, Luo Y, Tan Y, Zhu X, Zheng G, He J, Zheng WY Xie W, Li L, Ye X, Zhang J, Cai Z, Lin M, Huang H*.Clinical characteristics and outcome of isolated extramedullary relapse in acute leukemia after allogeneic stem cell transplantation: a single-center analysis. Leuk Res . 37(4):372-7.2013. (IF: 2.764)

He J, Zhu L, Ye X, Li L, Zhu J, Zhang J, Xie W, Shi J, Zheng W, Wei G, Sun J, CaiZ, Huang H*.  Clinical Characteristics and Prognosis of 23 Patients With 

Nonleukemic Myeloid Sarcoma. Am J Med Sci. Aug. 2013.(Epub ahead of print) (IF: 1.334)

Wang C, Xiao H, Ma J, Zhu Y, Yu J, Sun L, Sun H, Liu Y, Jin C, Huang H*. The F-box protein beta-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells. Biochem Biophys Res Commun. 434(4):728-34. 2013. (IF: 2.406)

Xie W, Zhao Y, Cao L, Huang W, Wang Y, Huang H*. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature.Med Oncol. 29(4):2417-22. 2012. (IF: 2.147)

Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, Zhang L, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H*. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica. 97 (12):1804-1812. 2012. (IF:5.935)

Hu Y, Gu Y, Cui Q, Fu H, Sheng L, Wu K, Liu L, Fu S, Yu X, Huang H*. Phytohemagglutinin - activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti - CD122 conditioned NOD/SCID mice. Ann Hematol . 91 (11): 1803-1822. 2012. (IF: 2.866)

Zhu Y, Wang C, Lan J, Yu J, Jin C. & Huang H*. Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis. Exp Cell Res. 318 (18), 2344-2352. 2012. (IF3.557)

Liu L, Hu K, Wang B, Huang H*,YuQ. Mobilization of endogenous stem cells: A new strategy for bone healing. Bone. 51 (3): 633-634. 2012. (IF: 3.823)

Wu W, Cao L, Li Y, Yu X, Huang H, He J*. Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai-Dorfman disease. Am J Med Sci. 344(2):155-9. 2012. (IF: 1.334)

Wu K, Luo Y, Liu L, Zhao Y, Hu Y, Tan Y, Lai X , Huang H*. Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review. J Int Med Res . 40:2409-15. 2012. (IF 0.958)

Wang T, Huang H,CH Tzeng, Wang P, Wu T, Sun J, Tang J, Hu J, Lin S, Kao R*. Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant .18:1939-44. 2012. (IF 3.94)

Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J*. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant. Biol Blood Marrow Transplant 18:1509-16. 2012. (IF 3.94)

Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H*. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS One 7(4): e34321. 2012. (IF:3.73)

Zhang L, Wang Y, Huang H*. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transplant. 26 (4): 511-519. 2012. (IF:1.634)

Sun J, Wang Z, Luo Y, Tan Y, David S.Allan, Huang H*. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia. Acta Haematol. 127:143-148. 2012. (IF: 0.894)

Xu Y, Liu L, Zhang L, Fu S, Li R, Hu K and Huang H*.Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. Folia Biol (Praha) . 58(6):221-30. 2012. (IF: 1.219)

Cao W, Xiao H, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Ye X, Yu X, Lin M, Cai Z,Huang H*. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 18(2): 273-279. 2012. (IF: 3.940)

Hu Y, LuoY, Tan Y, Shi J, Sheng L, Fu H, Liu L, Xu Y, Wu K, Xiao H, Zhang L, Yu X, Cai Z, Huang H*. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation. Stem Cells Dev. 21: 177-180. 2012. (IF: 4.670)

Chang T, Zheng W, Tsark W, Bates S, Huang H, Lin R, Yee JK*.  Phenotypic rescue of Induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells. 29: 2090-2093. 2011. (IF 7.701)

Wei G, Ni W, Chiao J, Cai Z, Huang H, Liu D*. A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol, 4: 46. 2011. (IF: 4.458)

Liu L, Wang Y, Wu K, Fu S, Zhang L, Xu Y, Huang H*. The tyrosine kinase inhibitor nilotinib inhibits proliferation and osteoblast differentiation of human mesenchymal stromal cells. Bone. 49(5):1117-1118. 2011. (IF: 3.823)

Liu L, Yu Q, Lin J, Lai X, Cao W, Du K, Wang Y, Wu K, Hu Y, Zhang L, Xiao H, Duan Y, Huang H*. Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 20(11):1961-71. 2011. (IF: 2.301)

Luo Y, Zhao Y, Tan Y, Shi J, Han X, Zheng Y, Li L, He J, Xie W, Ye X, Cai Z, Lin M, Huang H*. Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia. Leu Res. 35: 1307-1311. 2011. (IF: 2.764)

Zhao Y, Tan Y, Wu G, Liu L, Wang Y, Luo Y, Shi J, Huang H*. Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia. Int J Hematol. 94: 156-162. 2011. (IF: 1.681)

Hu Y, Cui Q, Liang B,Huang H* Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 17(8): 1099-1111. 2011. (IF: 3.94)

Tan Y, Fu H, Luo Y, Shi J, Ye X, Zheng Y, Xiao H, Hu Y, Huang H*.Haploidentical Allogeneic Haematopoietic Stem Cell Transplantation as Salvage Therapy for Engraftment Failure after Unrelated and Autologous Stem Cell Transplantation: a Case Report and Review of the Literature. J Int Med Res. 39: 950-959. 2011. (IF: 0.958)

Xiao H, Cao W, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng W, Zheng G, Han X, Jin L, Zhang L, Wang Y, Yu X, Cai Z, Lin M, Ye X, Huang H*. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in Chinese population. Biol Blood Marrow Transplant. 17: 542-549. 2011. (IF: 3.940)

Xiao H, Lai X, LuoY, Shi J, Tan Y, He J, Xie W, Li L, Zhu X, Zhu J, Sun J, Wei G,Jin L,Liu L,Wu K,Yu X, Cai Z, Lin M, Ye X, Huang H*. Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in Chinese population. Bone Marrow Transplant. 46: 400-407. 2011. (IF: 3.541)

Wang C, Yu J, Yuan K, Lan J, Jin C*, Huang H*.  Plk1-mediated phosphorylation of PinX1 regulates its stability. Eur J Cell Biol. 89(10): 748-756. 2010. (IF: 3.213)

Hu Y, Cui Q, Liang B, Huang H*.Donor-derived solid malignancies after hematopoietic stem cell transplantation. Onkologie. 33(4):195-200. 2010. (IF: 1.000)

Wu G, Zhao Y, Lai X, Luo Y, Tan Y, Shi J, Li L, Zheng W, Zhang J, Hu X, Jin A, He J, Xie W, Ye X, Cai Z, Lin M, Huang H*. The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population. Bone Marrow Transplant. 45: 1514-1521. 2010. (IF: 3.541)

Zheng W, Guan M, Zhu L, Cai Z, Chung V, Huang H*, Yen Y. Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells. Anticancer Res. 30(6): 1921-1930. 2010. (IF: 1.713)

Dong-Wook Kim*, Shripad D. Banavali, Udomsak Bunworasate, Yeow-Tee Goh, Peter Ganly, Huang H, Ian Irving, Saengsuree Jootar, Hyun-Gyung Goh, Liang-Piu Koh, Wei Li, Tomoki Naoe, Soo-Chin Ng, Visalachy Purushotaman, Harryanto Reksodiputro, Lee-Yung Shih, Jih-Luh Tang, Arinobu Tojo, Jianmin Wang, Raymond Wong. Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era. Leuk Res. 34(11): 1459-1471. 2010. (IF: 2.764)

Yu J, Lan J, Wang C, Wu Q, Zhu Y, Lai X, Sun J, Jin C*, Huang H*. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells. Cancer Lett. 291(2): 177-186. 2010. (IF: 4.258)

Wu G, Zhao Y, Lai X, Yang K, Zhu F, Zhang W, Wang W, Luo Y, Tan Y, Wang Y, Cao W, Huang H*. Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations. Tissue Antigens. 74(6): 499-507. 2009. (IF: 2.753)

Wu Q, Hu H, Lan J, Emenari C, Wang Z, Chang K, Huang H, Yao X*. PML3 Orchestrates the Nuclear Dynamics and Function of TIP60. J Biol Chem. 284(13):8747-8759. 2009. (IF: 4.651)

Luo Y, Lai X, Tan Y, Shi J, Zhao Y, Han X, Zheng G, Zhu X, Sun J, Zheng Y, Wu G, He J, Chen S, Jin A, Xie W, Ye X, Cai Z, Lin M, Huang H*. Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. Leukemia. 23(6):1171-1174. 2009. (IF: 10.164)

Zhao Y, Liu L, Wang Y, Wu G, Lai X, Cao W, Luo Y, Tan Y, Shi J, Xie W, Ye X, Cai Z, Lin M, Huang H*.Efficacy and Prognosis of Chronic Myeloid Leukemia Treated With Imatinib Mesylate in a Chinese Population. Int J Hematol. 89(4):445-451. 2009. (IF: 1.681)

Zhao Y, Wu G, Wu K, Liu L, Cao W, Yu X, Luo Y, Shi J, Tan Y, Huang H*. Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia. Leuk Res. 33(7):e85-87. 2009. (IF: 2.764)

Zheng W, Wei G, Ye X, He J, Li L, Wu W, Shi J, Zhang J, Huang W, Xie W, Luo Y, Xue X, Lin M, Huang H, Cai Z*. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience. Leuk Res. 33(12):1615-1618. 2009. (IF: 2.764)

Qiu L, He J*, Ye X, Xie W, Shi J, Zheng W, Sun J, Zhu X, Cai Z, Huang H, Lin M. Invasive pulmonary fungal infection accompanied by severe hemoptysis in patients with hematologic diseases: a report of nine cases. Int J Hematol. 90(1):108-112. 2009. (IF: 1.681)

Shi J, Cai Z*, Huang H, Ye X, He J, Xie W, Zhang J, Zhou X, Luo Y, Lin Y, Li L, Zheng W, Wei G, Lin M. Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases. Int J Hematol. 89(5):624-627. 2009. (IF: 1.681)

Yu J, Lan J, Zhu Y, Li X, Lai X, Xue Y, Jin C*, Huang H*. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem Biophys Res Commun. 367(4):805-812. Mar 2008. (IF: 2.406)  

Zhao YM, Li JY, Lan JP, Lai XY, Luo Y, Sun J, Yu J, Zhu YY, Zeng FF, Zhou Q, Huang H*. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 369(4): 1114-1119. May 2008. (IF: 2.406)  

Zhao YM, Zhou Q, Xu Y, Lai XY, Huang H*. Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition. Acta Pharmacol Sin.29(4):481-488. Apr 2008. (IF: 2.354)

Cheng Z, Ke Y, Ding X, Wang F, Wang H, Wang W, Ahmed K, Liu Z, Xu Y, Aikhionbare F, Yan H, Liu J, Xue Y, Yu J, Powell M, Liang S, Wu Q, Reddy SE, Hu R, Huang H, Jin C, Yao X*. Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response. Oncogene. 27(7): 931-941. Feb 2008. (IF: 7.357)

Luo Y, Zhang A, Huang H*, Zheng S. Haemolytic uraemic syndrome after living-donor liver transplantation:is small-for-size graft a potential risk factor? 

J Int Med Res. 36(3):599-604. May-Jun 2008. (IF: 0.958)

Li X, Lan J, Zhu Y, Yu J, Dou Z, Huang H*. Expression, purification, and characterization of Tara, a novel telomere repeat-binding factor 1 (TRF1)-binding protein. Protein Expr Purif. 55(1):84-92. Sep 2007. (IF: 1.429)

Sun J, Huang H, Zhu Y, Lan J, Li J, Lai X, Yu J*. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Int J Hematol. 82(3):215-222. Oct 2005. (IF: 1.681)

Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, Miao Y, Zhu Y, Shi Y, Zhu J, Huang H*, Yao X*. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene. 24(35): 5401-5413. Aug 2005 (IF: 7.357)


发表著作:

周晋,黄河(主编). 2009.《血液内科学》第一版,第二版,人民卫生出版社

黄河(副主编).2009.《2010西医综合考试辅导与模拟试题》,浙江大学出版社.

黄河(参编).2009.《内科学新进展》,浙江大学出版社

黄河(副主编).2003.《临床疾病与免疫》,科学出版社

黄河(参编).2002.《感染微生态学》,人民卫生出版社


发明专利:

名称:抗人骨髓间充质干细胞单克隆抗体ZUF10及应用,专利号:ZL 2005 1 0061032.3;                                        (排名第一)

名称:抗人骨髓间充质干细胞单克隆抗体ZUC3及应用,专利号:ZL 2005 1 0061033.8;                                        (排名第一)

名称:抗人骨髓间充质干细胞单克隆抗体ZUB1及应用,专利号:ZL 2005 1 0061034.2;                                        (排名第一)

名称:抗人骨髓间充质干细胞单克隆抗体ZUE12及应用,专利号:ZL 2005 10061035.7;                                        (排名第一)

名称:抗人骨髓间充质干细胞单克隆抗体ZUB4及应用,专利号:ZL 2005 1 0061036.1;                                        (排名第一)

名称:单抗ZUE12免疫磁珠分选人骨髓间充质干细胞的方法,专利号:ZL 2006 1 0050759.6;                                  (排名第一)

名称: 单抗ZUB1免疫磁珠分选原代人骨髓间充质干细胞的方法,专利号:ZL 2006 1 0050760.9;                               (排名第一)

名称: 单抗ZUC3免疫磁珠分选原代人骨髓间充质干细胞的方法,专利号:ZL 2006 1 0050761.3;                               (排名第一)

名称: 单抗ZUB4免疫磁珠分选原代人骨髓间充质干细胞的方法,专利号:ZL 2006 1 0050762.8;                               (排名第一)

名称: 单抗ZUF10免疫磁珠分选人骨髓间充质干细胞的方法,专利号:ZL 2006 1 0050763.2;                                  (排名第一)

名称:一种获得诱导多能干细胞的方法,专利号:ZL201110261281.2;

(排名第一)

名称:一种获得造血干细胞的方法,专利号:ZL201110300957.4;(排名第一)

名称:一种NOD/SCID小鼠异种移植物抗宿主病模型的建立方法,专利号:201210005931.1;(排名第一)

名称:一种调节性T细胞的诱导培养方法,专利号:ZL201110035687.9;(排名第一)

名称:用人间充质干细胞滋养层培养诱导多能干细胞的方法,专利号:ZL201110036898.4;(排名第一)

名称:雷帕霉素诱导调节性γδT细胞的培养方法,专利号:ZL201310384046.3;(排名第一)

名称:以IDLV为模板的TALEN靶向基因编辑优化方法,专利号: ZL201410059599.6;(排名第一)



在国际大型会议担任主席、特邀报告和口头报告:

Luo Y, Xiao H, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Zhu Y, Ye X, Cai Z, Lin M and Huang H*. Prospective evaluation of T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with contemporaneous matched sibling HSCT and unrelated HSCT: results from an open-label trial. 第40届欧洲血液与骨髓移植年会, 2014.3.30-4.2, Milan, Italy, 口头报告

Xiao H, Huang H*. Genomic Evolution and Genetic Alterations in Adult Patients with Philadephia Chromosome-negative Acute Lymphoblastic Leukemia from Diagnosis to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. 第40届欧洲血液与骨髓移植年会, 2014.3.30-4.2, Milan, Italy, 口头报告

Wang Y, Zhang L, Liu S, Huang H*. Defining Molecular Roadblocks through an Intermediate Standstill Derived during Reprogramming Human Fibroblast to iPS Cell. 第40届欧洲血液与骨髓移植年会, 2014.3.30-4.2, Milan, Italy, 口头报告

Hu K, Gu Y, Lou L, Liu L, Hu Y, Fu S, Wang B, Yu X, Huang H*. Bone marrow mesenchymal stromal cells protect acute leukemia cells from cytotoxic agents via galectin-3 mediated Wnt/β-catenin signaling. 第40届欧洲血液与骨髓移植年会, 2014.3.30-4.2, Milan, Italy, 口头报告

Xiao H, Luo Y, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, Fu S, Wang Y, Ye X, Yu X, Cai Z, and Huang H*. Whole-exome Sequencing of Adult Philadephia-negative Acute Lymphoblastic Leukemia from Diagnosis to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation Reveals Clonal Evolution and Relapse-associated Mutated Genes. 第55届美国血液学年会, 2013.12.7-10, Blood 2013 122:156, New Orleans, USA, 口头报告

Zhang M, Luo Y, Lai X, Tan Y, Zheng W, Zhu Y, Shi J, and Huang H*. Minimal residual disease levels at time of CR1 and transplant predict outcome in Philadephia chromosome-negative adult ALL. 第55届美国血液学年会, 2013.12.7-10, Blood 2013 122:713, New Orleans, USA, 口头报告

Huang H*. Biology, Prevention and Treatment of Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. 第18届亚太地区骨髓移植会议, 2013.11.1-4, Ho Chi Ming City, Vietnam, 特邀报告

Du K, Huang H*. A signal center analysis of Philadephia chromosome-positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in imatinib era. 第18届亚太地区骨髓移植会议, 2013.11.1-4, Ho Chi Ming City, Vietnam, 口头报告

Shi J, Huang H*. Epidemiology of invasive fungal infections in allogeneic stem cell transplantation recipients: risk factors for infection according to time after transplantation. 第18届亚太地区骨髓移植会议, 2013.11.1-4, Ho Chi Ming City, Vietnam, 口头报告

Hu Y, Huang H*. Reduced frequency of FOXP3+ gammadeta TCR+ regulatory T cells in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. 第18届亚太地区骨髓移植会议, 2013.11.1-4, Ho Chi Ming City, Vietnam, 口头报告

Tan Y, Huang H*.Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients post allogeneic hematopoietic stem cell transplantation. 第18届亚太地区骨髓移植会议, 2013.11.1-4, Ho Chi Ming City, Vietnam, 口头报告

Hu Y, Luo Y, Shi J, Tan Y, Zheng W, Cai Z, Huang H*.HBsAg- recipients had comparable outcomes and acquired HBV-specific humoral immunity after haematopoietic stem cell transplantation from HBsAg+ donors. Bone Marrow Transplant. 48(suppl 2): S29.第39届欧洲血液与骨髓移植年会, 2013.4.7-10, London, UK, 口头报告

Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, ZhangL, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H*.Genetic variations in graft-versus-leukemia reaction pathways and relapse risk after allogeneic hematopoietic stem cell Transplantation: an explore study. 美国国立卫生研究院第二届国际造血干细胞移植后复发工作会议, 2012.11.5-6, Washington, USA, 口头报告

Huang H*. Allogeneic transplantation in AML-CR1 in era of molecular markers. 第17届亚太地区骨髓移植会议, 2012.10.26-28, Hyderabad, India, 特邀报告

Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, Zhang L, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H*Genetic variations in Toll-like receptors and acute GVHD in allogeneic hematopoietic stem cell transplantation. 第17届亚太地区骨髓移植会议, 2012.10.26-28, Hyderabad, India, 口头报告

Hu Y, Gu Y, Wu K, Sheng L, Huang H*.Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice. 第17届亚太地区骨髓移植会议, 2012.10.26-28, Hyderabad, India, 口头报告

Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, Zhang L, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H*. Persistent cytomegalovirus reactivation and cytomegalovirus UL97 mutations in the seropositive haematopoietic stem cell transplantation setting. Bone Marrow Transplant. 47(suppl 2): S25.第38届欧洲血液与骨髓移植年会, 2012.4.1-4, Geneva, Switzerland, 口头报告

Hu Y, Gu Y, Sheng L, Wu K, Shi J, Tan Y, Yu X, and Huang H *. Decitabine -conditioned regulatory gamma delta T Cells provide enhanced protection from graft-versus-host disease via improved Foxp3 stability and ICOS up-regulation. Bone Marrow Transplant. 47(suppl 2): S72. 第38届欧洲血液与骨髓移植年会, 2012.4.1-4, Geneva, Switzerland, 口头报告

Wu KN, Hu YX, Fu HR, Sheng LX, and Huang H*. Ex Vivo-Expanded gamma&delta-T Cells Can Efficiently Kill Human Acute Myeloid Leukemia Cells Via Trogocytosis. 第53届美国血液学年会, 2011.12.10-13, Blood 2011; 118: 580, San Diego, USA, 口头报告

Huang H*. Biological advances and intervention in leukemia relapse following allogeneic hematopoietic stem cell transplantation. 第16届亚太地区骨髓移植会议, 2011.10.30-11.2, Sydney, Australia, 特邀报告

Xiao H, Luo Y, Shi J, Tan Y, He J, Xie W, Lai X, Yu X, Cai Z, Lin M, Ye X,

Huang H*.Donor Natural Killer Cell Activating Gene Polymorphisms Associated with the Risk of Early Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.第16届亚太地区骨髓移植会议, 2011.10.30-11.2, Sydney, Australia, 口头报告

Huang H*. Plasma Proteins: New Biomarkers in the Diagnosis and Treatment of   Complications of Allogeneic Hematopoietic Stem Cell Transplantat. 第7届中日生命科学研讨会, 2011.11.23-24, Kumamoto, Japan, 特邀报告

Induction of Hematopoietic Commitment from Adult Human Bone Marrow Mesenchymal Stem Cell-derived Induced Pluripotent Stem Cells with Cytokines. 第16届亚太地区骨髓移植会议, 2011.10.30-11.2, Sydney, Australia, 口头报告

Xiao H, Luo Y, Shi J, Tan Y, He J, Xie W, Lai X, Yu X, Cai Z, Lin M, Ye X,

Huang H*.Donor selection for natural killer cell activating genes leads to a reduced rate of relapse after allogeneic hematopoietic cell transplantation both for acute myeloid leukemia and acute lymphoblastic leukemia. Bone Marrow Transplant. 46(suppl 2): S73.第37届欧洲血液与骨髓移植年会, 2011.4.3-6, Paris, France, 口头报告

Xiao H, Luo Y, Shi J, Tan Y, He J, Xie W, Lai X, Yu X, Cai Z, Lin M, Ye X,

Huang H*.Association between genetic variants in T-cell costimulatory molecule and outcome after unrelated hematopoietic cell transplantation.Bone Marrow Transplant. 46(suppl 2): S18.第37届欧洲血液与骨髓移植年会, 2011.4.3-6, Paris, France, 口头报告

Xiao H, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Zhang L, Wang Y, Cai Z, Lin M,

Ye X, and Huang H*.T-cell costimulatory molecule genotypes are associated with the risk of early cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. 2011年美国血液学会骨髓移植年会, 2011.2.17-21, Honolulu, USA, 口头报告

Xiao H, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Zhang L, Wang Y, Cai Z, Lin M, Ye X, and Huang H*. The Genotype of T-cell Costimulatory Molecule is Associated with Relapse Incidence in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. 第52届美国血液学年会, 2010.12.4-7, Blood 2010; 116: 684, Orlando, USA, 口头报告

Huang H*. Recent advances and choices of transplantation conditioning regimen.第15届亚太地区骨髓移植会议, 2010.10.28-31, Phuket, Thailand, 主席, 特邀报告

Xiao H, Zhu X, Cao W, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Zhang L, Wang

Y, Cai Z, Lin M, Ye X, and Huang H*. Effect of low-dose, short-course mycophenolate mofetil as GVHD prophylaxis and study of the polymorphisms of target gene of mycophenolate mofetil.第15届亚太地区骨髓移植会议, 2010.10.28-31, Phuket, Thailand, 口头报告, 口头报告二等奖

Xiao H, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng G, Han X, Yu X,Cai Z, Lin M, Ye X, Huang H*.Donor and recipient TGF-beta 1 gene polymorphisms are associated with the risk of early cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 45(suppl 2): S37.第36届欧洲血液与骨髓移植年会, 2010.3.21-24, Vienna, Austria, 口头报告

Huang H*. New advances in the research of graft-versus-host disease after allo-HSCT. 2010年台湾血液学年会, 2010.4.9, Taiwan, 特邀报告

Huang H*. Cross-Straits Summit in Managing Acute Leukemia: Challenges and Options in 2010 and Beyond. 2010年台湾血液学年会, 2010.4.9, Taiwan, 主席

Huang H*. Reduced intensity transplantation: current role and future prospects. 第一届东亚血液学联盟会议, 2010.4.22-24, Kuala Lumpur, Malaysi, 特邀报告

Huang H*. Transplantation in autoimmune disease. 第一届东亚血液学联盟会议, 2010.4.22-24, Kuala Lumpur, Malaysi, 特邀报告

Huang H*. China consensus of CML treatment 2010. 2010年亚太慢性粒细胞白血病顾问委员会会议, 2010.4.25, Kuala Lumpur, Malaysi, 特邀报告

Huang H*. Advance of mesenchymal stem cell research and application in clinic.第4届西澳分子与细胞治疗论坛, 2010.4.26-5.7, The University of Western Australia, 特邀报告

Huang H*. Prophylaxis and treatment of graft-versus-host disease following allo-HSCT. 第14届亚太地区骨髓移植会议, 2009.8.27-29, Seoul, Korea, 主席, 特邀报告

Xiao H, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng G, Han X, Yu X, Cai Z, Lin M, Ye X, Huang H*Association between tumor necrosis factor-α gene polymorphisms and acute graft-versus-host disease in unrelated donor allogeneic haematopoietic stem cell transplantation in Chinese population. 第14届亚太地区骨髓移植会议, 2009.8.27-29, Seoul, Korea, 口头报告

Lai X, Huang H*, Huang L, Cao J, Zeng F, Zheng J. Identification and enrichment of human bone marrow derived mesenchymal stem cells by monoclonal antibody, ZUC3. Bone Marrow Transplant. 41(suppl.1):S16. 第34届欧洲血液与骨髓移植年会, 2008.3, Flroence, Italy, 口头报告

Huang H*, Fan J, Lai X, Yu Q, Ding W, Wang Y. Intracerebral transplantation of human mesenchymal stem cells after hypoxic-ischemic brain damage in rat. 第34届欧洲血液与骨髓移植年会, 2008.3, Flroence, Italy, 口头报告

Huang H*. Allogeneic Transplantation for Acute Lymphoblastic Leukemia. 2007年美国血液肿瘤治疗进展研讨会, New York, USA, 特邀报告

Huang H*. Treatment Strategies for Adult Acute Lymphoblastic Leukemia: Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in First Complete Remission. 第12届亚太地区骨髓移植会议, 2007.9, Beijing, China, 特邀报告

Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for 128 Patients with Hematological Malignancy. 第11届亚太地区骨髓移植会议, 2006.10, Nagoya, Japan, 口头报告

Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for Leukemia and Myelodysplastic Syndrome. 2006年亚太骨髓捐献者登记组织会议, 2006.4, Taiwan, 特邀报告

Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for Leukemia and Myelodysplastic Syndrome. 第10届亚太地区骨髓移植会议, 2005.10, Hangzhou, China, 特邀报告


国际权威杂志收录大会论文摘要:

H Xiao, Y Luo, L-M Wang, X Lai, S Fu, Y Wang, J Shi, Y Tan, W Zheng, H Huang*. Genomic evolution and genetic alterations in adult patients with philadephia chromosome-negative acute lymphoblastic leukemia from diagnosis to relapse after allogeneic hematopoietic stem cell transplantation. (2014). Bone Marrow Transplant. 49(suppl 1): S7.(Meeting Abstract) (Oral presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

K Hu, Y. Gu, L Lou, L Liu, Y Hu, H Huang*. Bone marrow mesenchymal stromal cells protect acute leukemia cells from cytotoxic agents via galectin-3 mediated WNT/Β-catenin signaling. (2014). Bone Marrow Transplant. 49(suppl 1): S11.(Meeting Abstract) (Oral presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Y Luo, H Xiao, X Lai, J Shi, Y Tan, J He, W Xie, W Zheng, Z Cai, M Lin, 

H Huang*. Prospective evaluation of T-cell-replete haplodentical HSCT with low-dose anti-T-lymphocyte globulin compared with contemporaneous matched sibling HSCT and unrelated HSCT: results from an open-label trial. (2014). Bone Marrow Transplant. 49(suppl 1): S29.(Meeting Abstract) (Oral presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

B Wang, Y Hu, R Tie, Y He, S Fu, L Sheng, X Yu, H Huang*.Phenotypical and functional characterization of in vitro expanded bone marrow mesenchymal stem cells from patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (2014). Bone Marrow Transplant. 49(suppl 1): S192.(Meeting Abstract) (Poster presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

C Zhang, Y Hu, Y Luo, Y Tan, H Huang*. MIRSNPS are associated with aGVHD after unrelated allo-HSCT in Chinese han population. (2014). Bone Marrow Transplant. 49(suppl 1): S300.(Meeting Abstract) (Poster presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

L Sheng, H Fu, Y Hu, Y Luo, J Shi, Y Tan, Y He, X Lai, H Huang*. Impaired NK cells cytotoxicity against activated alloreactive donor T cells in GVHD can be partly restored by IL-15 ex vivo. (2014). Bone Marrow Transplant. 49(suppl 1): S301.(Meeting Abstract) (Poster presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Y Hu, Y Luo, Y Tan, Y Gu, H Huang*. Serum IL-2 levels regulate chronic graft versus host disease severity via CD4+FOXP3+regulatory T cell homeostasis after allogeneic hematopoietic stem cell transplantation. (2014). Bone Marrow Transplant. 49(suppl 1): S302.(Meeting Abstract) (Poster presentation, 40th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Haowen Xiao, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Li-Mengmeng Wang, Shan Fu, Lifei Zhang, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, and He Huang*. (2013). Donor Toll-Like Receptor 9 Genetic Factors in Susceptibility to Acute Graft-Versus-Host Disease and Cytomegalovirus Infection After Related and Unrelated Hematopoietic Stem Cell Transplantation. Blood. 120: 1938. (Meeting Abstract) (Poster Presentation, 54th the American Society Hematology Annual Meeting)

Haowen Xiao, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Li-Mengmeng Wang, Shan Fu, Yebo Wang, Xiujin Ye, Xiaohong Yu, Zhen Cai, He Huang*(2013). Whole-Exome Sequencing Of Adult Philadephia-Negative Acute Lymphoblastic Leukemia From Diagnosis To Relapse After Allogeneic Hematopoietic Stem Cell Transplantation Reveals Clonal Evolution and Relapse-Associated Mutated Genes. Blood 2013 122:156.(Meeting Abstract) (Oral Presentation,55th the American Society Hematology Annual Meeting)

Yajian Jiang, De Zhou, Wanzhuo Xie, Jingsong He, Jimin Shi, Yi Luo, Jie Zhang, Maofang Lin, Xiujin Ye, Zhen Cai, He Huang* (2013). Clinical Outcome Of R-CHOP Or CHOP Regimen For Elderly Patients With Diffuse Large B-Cell Lymphoma In China:A Single Center’s Experience. Blood 2013 122:5098. (Meeting Abstract) ( 55th the American Society Hematology Annual Meeting) 

Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Yuanyuan Zhu, Xiujin Ye, Zhen Cai, Maofang Lin, He Huang* (2013).Prospective Evaluation Of Allo-HSCT From Haploidentical-Related Donors Compared With Matched Sibling Donors and Unrelated Donors For Patients With Hematological Malignancies: Results From An Open-Label Trial. Blood 2013 122:3338. (Meeting Abstract) (Poster Presentation, 55th the American Society Hematology Annual Meeting)

Yanjun Gu, Yongxian Hu, Kaimin Hu, Weichao Liao, Feilin Zheng, Xiaohong Yu, He Huang*.(2013) Rapamycin Together With TGF-β1, IL-2 and IL-15 Induces The Generation Of Functional Regulatory γδT Cells From Human Peripheral Blood Mononuclear Cells. Blood 2013 122:3482. (Meeting Abstract) (Poster Presentation, 55th the American Society Hematology Annual Meeting)

Xiaoyu Lai, Mingyu Zhu, Yi Luo, Yamin Tan, Weiyan Zheng, Yuanyuan Zhu, Jimin Shi, He Huang* (2013). Comparison Of Allogeneic Hematopoietic Cell Transplantation Versus Chemotherapy In Patients With Acute Myeloid Leukemia In First Remission. Blood 2013 122:5546. (Meeting Abstract) (55th the American Society Hematology Annual Meeting)

Mingming Zhang, Yi Luo, Xiaoyu Lai, Yamin Tan, Weiyan Zheng, Yuanyuan Zhu, Jimin Shi, He Huang* (2013). Minimal Residual Disease Levels At Time Of CR1 and Transplant Predict Outcome In Philadelphia Chromosome-Negative Adult ALL. Blood 2013 122:713. (Meeting Abstract) (Oral Presentation, 55th the American Society Hematology Annual Meeting)

Haowen Xiao, Wang Li-Mengmeng, Binsheng Wang, Chong Wang, Lifei Zhang, Shan Fu, Yebo Wang, He Huang*.(2013) CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells. Blood 2013 122:2519. (Meeting Abstract) (Poster Presentation, 55th the American Society Hematology Annual Meeting)

Yongxian Hu, Yi Luo, Weiyan Zheng, Yamin Tan, He Huang*.(2013) Foxp3+ Regulatory T Cell Subsets Are Induced In Alloreactive Microenvironment and Associated With Chronic Graft-Versus-Host Disease Severity After Allogeneic Hematopoietic Stem Cell Transplantation. Blood 2013 122:3307. (Meeting Abstract) (Poster Presentation, 55th the American Society Hematology Annual Meeting)

Yiran Zhang, Kaimin Hu, Yongxian Hu, Binsheng Wang, He Huang*.(2013). Bone Marrow Mesenchymal Stem Cells Affect The Cell Cycle Arrest Effect Of Genotoxic Agents On Acute Lymphocytic Leukemia Cells Via p21 Down-Regulation. Blood 2013 122:4988. (Meeting Abstract) (55th the American Society Hematology Annual Meeting)

Yongxian Hu, Yi Luo, Jimin Shi, Yamin Tan, Weiyan Zheng, Zhen Cai, He Huang*.(2013). HBsAg- recipients had comparable outcomes and acquired HBV-specific humoral immunity after haematopoietic stem cell transplantation from HBsAg+ donors. Bone Marrow Transplant. 48(suppl 2): S29 (Meeting Abstract) (Oral presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation ) 

Haowen Xiao Li-Mengmeng Wang, Chong Wang, Lifei Zhang, Shan Fu, Yebo  

Wang, He Huang*. (2013). CEBPA gene different mutants involved in the etiological mechanisms of donor cell leukemia play distinct roles in blockage of C/EBP-alpha function. Bone Marrow Transplant. 48(suppl 2): S411 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Haowen Xiao, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, and He Huang*. (2013). Genetic variations in graft-versus-leukemia reaction pathways and relapse risk after allogeneic hematopoietic stem cell transplantation: an explore study. Bone Marrow Transplant. 48(suppl 2): S250 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Kangni Wu, Yin He, Huarui Fu, Yongxian Hu, Lixia Sheng, He Huang*. (2013).  

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differently affect T- cell reactivity in a long-term induction ex-vivo environment. Bone Marrow Transplant. 48(suppl 2): S76 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Yinjia Wang, L. Lenaeus, R. Mares, T. Chang, He Huang* and J. Yee.  

Establishment of integration-free iPS cell lines from Wiskott-Aldrich syndrom patient fibroblasts capable of differentiation into the monocytic lineage through ex vivo culture system. Bone Marrow Transplant. 48(suppl 2): S157 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Kangni Wu, Yin He, Huarui Fu, Yongxian Hu, Lixia Sheng, He Huang*. (2013). V 9V 2 T Cells recognize and kill chenotherapy-resistant acute myeloid leukemia cells via movement of lytic granules controlled by CD226 participated ERK1/2 phosphorylation. Bone Marrow Transplant. 48(suppl 2): S160 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Jie Sun, Shan Fu, Weijun Zhong, Ni Zhu, He Huang*. (2013). Over-expression of PML can inhibit proliferation and promote osteogenic differentiation in human mesenchymal stem cells. Bone Marrow Transplant. 48(suppl 2): S261 (Meeting Abstract) (Poster presentation, 39th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Haowen Xiao, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Li-Mengmeng Wang, Shan Fu, Lifei Zhang, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, and He Huang*. (2012). Donor Toll-Like Receptor 9 Genetic Factors in Susceptibility to Acute Graft-Versus-Host Disease and Cytomegalovirus Infection After Related and Unrelated Hematopoietic Stem Cell Transplantation. Blood. 120: 1938. (Meeting Abstract) (Poster Presentation, 54th the American Society Hematology Annual Meeting)

Jimin Shi, Xiaojian Meng, Yi Luo, Yamin Tan, Xiaoli Zhu, Gaofeng Zheng, Jingsong He, Weiyan Zheng, Wanzhuo Xie, Li Li, Xiujin Ye, Jie Zhang, Zhen Cai, Maofang Lin, and He Huang*. (2012). Clinical Characteristics and Outcome of Isolated Extramedullary Relapse in Acute Leukemia Following Allogeneic Stem Cell Transplantation: A Single Institutional Analysis. Blood. 120: 4211. (Meeting Abstract) (Poster Presentation, 54th the American Society Hematology Annual Meeting)

Yongxian Hu, Yanjun Gu, Lixia Sheng, Kangni Wu, Jimin Shi, Yamin Tan, Xiaohong Yu, and He Huang*. (2012). Decitabine Facilitates the Generation of Functional Regulatory T Cells Via Foxp3 Gene Demethylation and NF- B up-Regulation. Blood 120: 3281. (Meeting Abstract) (Poster Presentation, 54th the American Society Hematology Annual Meeting)

Yi Luo, Yamin Tan, Xiaoyu Lai, Weiyan Zheng, Jimin Shi, Gaofeng Zheng, and He Huang*. (2012). Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Blood. 120: 4159. (Meeting Abstract) (Poster Presentation, 54th the American Society Hematology Annual Meeting)

Kaimin Hu, Lizhen Liu, Binsheng Wang, Kangni Wu, Shan Fu, Yanjun Gu, Xiaoyu Lai, Xiaohong Yu, and He Huang*. (2012). Bone Marrow Mesenchymal Stromal Cells Protect Acute Lymphocytic Leukemia Cells From Cytotoxic Agents Via MAPK/Erk and Wnt/β-Catenin Signal Pathways. Blood. 120: 4736. (Meeting Abstract)

Wanzhuo Xie, Keyue Hu, Fan Xu, De Zhou, Weijia Huang, Li Li, Jingsong He, Jimin Shi, Yi Luo, Jingjing Zhu, Guoqing Wei, Jie Zhang, Maofang Lin, Xiujin Ye, Zhen Cai, and He Huang*. (2012). Significance of Clinical Factors As Prognostic Indicators for Mature T-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis of Chinese Cases. Blood. 120: 5093. (Meeting Abstract)

Haowen Xiao, Yi Luo, Shan Fu, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Xiaoyu Lai, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, He Huang*. (2012).Persistent cytomegalovirus reactivation and cytomegalovirus UL97 mutations in the seropositive hematopoietic stem cell transplantation setting. Bone Marrow Transplant. 47 (suppl 2): S25 (Meeting Abstract) (Oral presentation, 38th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Yongxian Hu, Yanjun Gu, Kangni Wu, Lixia Sheng, He Huang*. (2012). Persistent cytomegalovirus reactivation and cytomegalovirus UL97 mutations in the seropositive hematopoietic stem cell transplantation setting. Bone Marrow Transplant. 47 (suppl 2): S72 (Meeting Abstract) (Oral presentation, 38th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Haowen Xiao, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Xiaoyu Lai, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, He Huang*. (2012). Genetic variations in Toll-like receptor pathway are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Bone Marrow Transplant. 47 (suppl 2): S150 (Meeting Abstract) (Poster presentation, 38th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Haowen Xiao, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Xiujin Ye, Zhen Cai, Maofang Lin*, and He Huang*. (2011). Genetic Variation in the Effector Pathways of Cytotoxic T Lymphocytes Influences Alloimmune Reactivities Following Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 118: 3054. (Meeting Abstract) (Poster Presentation, 53rd the American Society Hematology Annual Meeting)

Yongxian Hu, Yi Luo, Yamin Tan, Xiaoyu Lai, Jimin Shi, Jingsong He, Gaofeng Zheng, Weiyan Zheng, Wanzhuo Xie, Zhen Cai, and He Huang*. (2011). Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy. Blood. 118: 1949. (Meeting Abstract) (Poster Presentation, 53rd the American Society Hematology Annual Meeting)

Kangni Wu, Yongxian Hu, Huarui Fu, Lixia Sheng, and He Huang*. (2011).

Ex Vivo-Expanded V 9V 2 T Cells Can Efficiently Kill Human Acute Myeloid Leukemia Cells Via Trogocytosis. Blood. 118: 580. (Meeting Abstract) (Oral Presentation, 53rd the American Society Hematology Annual Meeting)

Yongxian Hu, Yanjun Gu, Lixia Sheng, Huarui Fu, Kangni Wu, Lifei Zhang, Lizhen Liu, Shan Fu, Yulin Xu, Haowen Xiao, Xiaohong Yu, and He Huang*. (2011). Decitabine Can Increase the Induction of Regulatory T Cells with Enhanced Immunosuppression on Graft-Versus-Host Disease From Adult Human Peripheral Blood Mononuclear Cells. Blood. 118: 1901. (Meeting Abstract) (Poster Presentation, 53rd the American Society Hematology Annual Meeting)

Yulin Xu, Lizhen Liu, Shan Fu, Lifei Zhang, Yongxian Hu, Senquan Liu, Yingjia Wang, Huarui Fu, Kangni Wu, Haowen Xiao, Xiaohong Yu, Weiyan Zheng, and He Huang*. (2011). Efficient Induction of CD34+ Progenitor Cells From Human Bone Marrow Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells with Defined Chemicals. Blood. 118: 2347. (Meeting Abstract) (Poster Presentation, 53rd the American Society Hematology Annual Meeting)

Lizhen Liu, Qin Yu, Shan Fu, Hui Dong, Kaimin Hu, Lifei Zhang, Senquan Liu, Xiaohong Yu, and He Huang*. (2011). Mesenchymal Stromal Cells with Immunosuppressive Potential Can Be Mobilized Into Peripheral Blood by Electro-Acupuncture. Blood. 118: 4805. (Meeting Abstract)

Haowen Xiao, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Xiaoyu Lai, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2011). Donor selection for natural killer cell activating genes leads to a reduced rate of relapse after allogeneic hematopoietic cell transplantation both for acute myeloid leukemia and acute lymphoblastic leukemia. Bone Marrow Transplant. 46 (suppl 2): S73 (Meeting Abstract) (Oral presentation, 38th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Haowen Xiao, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Xiaoyu Lai, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2011). Association between genetic variants in T-cell costimulatory molecule and outcome after unrelated hematopoietic cell transplantation. Bone Marrow Transplant. 46 (suppl 2): S18 (Meeting Abstract) (Oral presentation, 38th Annual Meeting of the European Group for Blood and Marrow Transplantation ).

Haowen Xiao, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He,Wanzhuo Xie, Lifei Zhang, Yingjia Wang, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2010). The Genotype of T-cell Costimulatory Molecule is Associated with Relapse Incidence in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. Blood. 116 (21): 684. (Meeting Abstract). (Oral Presentation, 52nd the American Society Hematology Annual Meeting)

Yi Luo, Yamin Tan, Xiaoyu Lai, Shi jimin, Zheng Weiyan, He Huang*. (2010). HLA-haploidentical Stem Cell Transplantation for Malignant Hematological Diseases Using G-CSF Mobilized Bone Marrow and Peripheral Blood Stem Cells. Blood. 116 (21): 2384. (Meeting Abstract). (Poster Presentation, 52nd the American Society Hematology Annual Meeting)

Haowen Xiao, Jimin Shi, Yi Luo, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng,Gaofeng Zheng,Xiaoyan Han, Lifei Zhang, Yingjia Wang, Lizhen Liu, Kangni Wu, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2010). Multiple Mutations of CEBPA Contribute to Leukemogenesis: the Donor Origin of Leukemia Relapse after Allogeneic Hematopoietic Cell Transplantation. Blood. 116 (21): 1303. (Meeting Abstract). (Poster Presentation, 52nd the American Society Hematology Annual Meeting)

Lifei Zhang, Haowen Xiao, Weijie Cao, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Li Li, Xiaoli Zhu, Jingjing Zhu, Jie Sun, Guoqing Wei, Yingjia Wang, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2010). The Association of the Polymorphisms of IMPDH1 Gene and Acute Graft-versus-Host Disease after Related and Unrelated Hematopoietic Stem Cell Transplantation. Blood. 116 (21): 2377. (Meeting Abstract). (Poster Presentation, 52nd the American Society Hematology Annual Meeting)

Lizhen Liu, Qin Yu, Jie Lin, Weijie Cao, Xiaoyu Lai, Kaili Du, Yinjia Wang, He Huang*. (2010). Mesenchymal Stem Cells Can Be Mobilized into Peripheral Blood by Short-term Hypoxia: a Possible Role of HIF-1α. Blood. 116 (21): 1450. (Meeting Abstract). (Poster Presentation, 52nd the American Society Hematology Annual Meeting)

Zhu XL, Lai XY, Luo Y, Shi JM, Tan YM, H Huang*. (2010). Combination of Mycophenolate Mofetil with Cyclosporine A and Methotrexate as GVHD Prophylaxis in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 116 (21): 1280. (Meeting Abstract). (Poster Presentation, 52nd the American Society Hematology Annual Meeting)

H. Xiao, X. Lai, Y. Luo, J. Shi, Y. Tan, J. He, W. Xie, X. Meng, G. Zheng, X. Han, X. Yu, Z. Cai, M. Lin, X. Ye, H Huang*. (2010) Donor and recipient TGF-beta 1 gene polymorphisms are associated with the risk of early cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 45(suppl 2): S37 (Meeting Abstract) (Oral presentation, 36th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Xiao H, Lai X, Wu G, Luo Y, Shi J, Tan Y, Han X, Zhu X, Zhu J, Xie W, He J, Zhen Cai, Lin M, Ye X, Huang H*. (2010). Relation of TNFA, TNFB and TNFRII Gene Polymorphisms to Outcomes after Unrelated Haematopoietic Cell Transplantation within Chinese Population. Biol Blood Marrow Transplant 16(supple2): S276 (Meeting Abstract) (Poster presentation, 2011 BMT Tandem Meetings)

Xiao H, Lai X, Wu G, Luo Y, Shi J, Tan Y, Han X, Zhu X, Zhu J, Xie W, He J, Zhen Cai, Lin M, Ye X, Huang H*. (2010). Immunosuppressive Cytokine Gene Polymorphisms and Outcomes after Related and Unrelated Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant 2010,16(supple2): S271 (Meeting Abstract) (Poster presentation, 2011 BMT Tandem Meetings)

Haowen Xiao, Xiaoyu Lai, Gongqiang Wu, Yi Luo, Jimin Shi, Yamin Tan, Xiaoyan Han, Wenjun Wu, Wanzhuo Xie, Xiaoli Zhu, Jingsong He, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2009). Donor inflammatory gene polymorphisms are associated with early bacterial infection after unrelated allogeneic haematopoietic stem cell transplantation. Blood. 114(22): 1159 (Meeting Abstract) (Poster Presentation, 51st the American Society Hematology Annual Meeting)

Haowen Xiao, Xiaoyu Lai, Gongqiang Wu, Yi Luo, Jimin Shi, Yamin Tan, Xiaoyan Han, Xiaoli Zhu, Jingjing Zhu, Wanzhuo Xie, Xiaoli Zhu, Jingsong He, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang*. (2009). Association between TNF and TNF receptor II gene polymorphisms and acute graft-versus-host disease in unrelated donor allogeneic haematopoietic stem cell transplantation within Chinese population. Blood. 114(22): 1158. (Meeting Abstract) (Poster Presentation, 51st the American Society Hematology Annual Meeting)

Huang H*, Wu Gongqiang, Lai Xiaoyu, Tan Yamin, Luo Yi, Zhu Faming.(2009) Distribution of killer cell immunoglobulin-like receptor genes in East China and Taiwanese populations. Bone Marrow Transplant. 43(Suppl. 1): S S293-S293. (Meeting Abstract) (Poster Presentation, 35th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Huang H*, Wu Gongqiang, Lai Xiaoyu, Tan Yamin, Luo Yi, Zhu Faming. (2009) The effect of donor KIR and patient HLA genotypes on outcome following allogeneic haematopoietic stem cell transplantation in a Chinese population. Bone Marrow Transplant. 43(Suppl.1): S303-S303. (Meeting Abstract) (Poster Presentation, 35th Annual Meeting of the European Group for Blood and Marrow Transplantation )

Luo Yi, Tan Yamin, Shi Jimin, Han Xiaoyan, Zheng Gaofeng, Zhu Xiaoli, Lai Xiaoyu, Huang H*.(2009) Inmatinib combined myeloablative allogenetic haematopoietic stem cell transplantation for advanced chronic myeloid leukaemia. Bone Marrow Transplant. 43(Suppl. 1): S384-S384. (Meeting Abstract) (35th Annual Meeting of the European Group for Blood and Marrow Transplantation )

He Huang*, Yi Luo, Jimin Shi, Wanzhuo Xie, Wenjun Wu, Jingsong He, Jie Zhang, Xiujin Ye, Zhen Cai, Maofang Lin. (2008) Comparable Outcomes of Sbling and Unrelated Donors Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Blood. 112(11): 4417. (Meeting Abstract) (50th the American Society Hematology Annual Meeting)

He Huang*, Yi Luo, Jimin Shi, Yamin Tan, Xiaoyan Han, Xiaorong Hu, Aiyun Jin, Shuiyun Chen, Maofang Lin. (2008) Impact of HLA High-Resolution Matching on Outcomes of Myeloablative Unrelated Donor Hematopoietic Stem Cell Transplantation in Chinese Population. Blood. 112(11): 4361. (Meeting Abstract) (50th the American Society Hematology Annual Meeting)

He Huang*, Gongqiang Wu, Xiaoyu Lai, Yamin Tan, Yi Luo, Faming Zhu. (2008) The Distribution of KIR Gene in Chinese Population and the Effect of Donor KIR and Patient HLA Genotypes on Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 112(11): 2236. (Meeting Abstract) (50th the American Society Hematology Annual Meeting)

Jimin Shi, He Huang*, Zhen Cai, Yi Luo, Weiyan Zheng, Jingsong He, Wanzhuo Xie, Li Li, Xiujin Ye, Jie Zhang, Maofang Lin. (2008) Busulfan and Cyclophosphamide for Hemopoietic Stem Cell Transplantation from Related and Unrelated Donors in Patients with Myelodysplastic Syndrome. Blood. 112(11): 4429. (Meeting Abstract) (50th the American Society Hematology Annual Meeting)

Yamin Tan, He Huang*, Yi Luo, Jimin Shi, Zhen Cai, Maofang Lin. (2008) Neurological complications following allogeneic haematopoietic stem cell transplantation. Blood. 112(11): 4307. (Meeting Abstract) (50th the American Society Hematology Annual Meeting)

Lai Xiaoyu, Huang H*, Huang Li, Cao Junli, Zeng Fengfang, Zheng Jin. (2008) Identification and enrichment of human bone marrow derived mesenchymal stem cells by monoclonal antibody, ZUC3. Bone Marrow Transplant. 41(Suppl. 1):S16-S16. (Meeting Abstract) (Oral Presentation, 34th Annual Meeting of the European Group for Blood and Marrow Transplantation)

Huang He*, Fan Jianling, Lai Xiaoyu, Yu Qin, Ding Wei, Wang Yan. (2008) Intracerebral transplantation of human mesenchymal stem cells after hypoxic-ischaemic brain damage in rat. Bone Marrow Transplant. 41(Suppl. 1):S16-S16. (Meeting Abstract) (Oral Presentation, 34th Annual Meeting of the European Group for Blood and Marrow Transplantation)

Huang He*, Lai Xiaoyu, Luo Yi, Shi Jimin, Cai Zhen, Lin Maofang. (2008) Graft-versus-leukaemia effect after unrelated donor haematopoietic stem cell transplantation for acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant. 41(Suppl. 1):S108-S108. (Meeting Abstract) (Poster Presentation, 34th Annual Meeting of the European Group for Blood and Marrow Transplantation)

Luo Yi, Huang He*, Tan Yamin, Han Xiaoyan, Zhu Xiaoli, Lai Xiaoyu, Cai Zhen, Lin Maofang. (2008) Non-myeloablative stem cell transplantation with imatinib for chronic myeloid leukaemia in chronic phase. Bone Marrow Transplant. 41(Suppl. 1):S438-S438. (Meeting Abstract) (34th Annual Meeting of the European Group for Blood and Marrow Transplantation)

He Huang*, Xiaoyu Lai, Yi Luo, Jimin Shi, Zhen Cai, and Maofang Lin. (2007) Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in First Complete Remission. Blood. 110(11): 5077. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Yun Xu, He Huang*, Yanmin Zhao, Fenfang Zeng, and Qian Zhou. (2007) Effects of Celecoxib on Human Acute Promyelocytic Leukemia Cell Line and Its Mechanism. Blood. 110(11):2851. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Yi Luo, He Huang*, Yamin Tan, Xiaoyan Han, Xiaoli Zhu, Xiaoyu Lai, Cai Zhen, and Maofang Lin. (2007) Imatinib Combined with Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia. Blood. 110(11):2966. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Yanmin Zhao, Yun Xu, Jianping Lan, Yuanyuan Zhu, and He Huang*. (2007) Anti-Proliferative Effect of Rapamycin on Human T Cell Leukemia Cell Line Jurkat by Cell Cycle Arrest and Telomerase Inhibition. Blood. 110(11): 4285. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Zhen Cai, Jimin Shi, He Huang*, Yu Lin, Xiujin Ye, Jingsong He, Wanzhuo Xie, Jie Zhang, Li Li, Weiyan Zheng, Guoqing Wei, Yi Luo, Buwen Zhang, Maofang Lin. (2007) The value of CT-guided percutaneous lung biopsy in the diagnosis of pulmonary fungal infections in patients with hematologic diseases. Blood. 110(11):3860. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Jian Yu, Jianping Lan, Yuanyuan Zhu, Xiaoyu Lai, He Huang*. (2007) Sumoylation of TRF1 Is Essential for Its Recruitment to ALT-Associated PML Bodies. Blood. 110(11):4169. (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Zhen Cai, Jingsong JS, Jiming, Li Li, Xiaoyan Han, Qunyi Guo, Hui Zhou, Buwen Zhang, He Huang*, Maofang Lin. (2007) The effect of CAHB on myelodysplastic syndrome in vitro and its application in a prospective clinical trial. Blood. 110(11): 4628 (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

Xiu Jing Ye, Weiwei Liao, Jingsong He, He Huang*. (2007) HHV-6 reactivation after hematopoietic stem cell transplantation in Chinese patients is associated with aGVHD. Blood. 110(11): 4995 (Meeting Abstract) (49th the American Society Hematology Annual Meeting)

He Huang*, Jing Zheng, Xiaoyu Lai, Junli Cao, Jianling Fan. (2006) Biological Characteristics of ZUC3 Antigen Expressed on Rat Bone Marrow Mesenchymal Stem Cells. Blood. 108 (11):4254. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

He Huang*, Zhen Cai, Jimin Shi, Yi Luo, Maofang Lin. (2006) Outcomes of Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancy: A Single Centers Experience. Blood. 108 (11):5410. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

He Huang*, Jingyuan Li, Jianping Lan, Yanmin Zhao, Xiaoyu Lai. (2006) The Underlying Mechanism of Telomere Maintenance in Human Bone Marrow-Derived Mesenchymal Stem Cells. Blood. 108 (11):4252. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

He Huang*, Jianling Fan, Qin Yu, Wei Ding, Xiaoyu Lai. (2006) Study on the Therapic Effect of Intracerebral Transplantation of Human Mesenchymal Stem Cells in Rats with Hypoxic-Ischemic Brain Damage. Blood. 108(11):2571. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Xiaoyu Lai, He Huang*, Li Huang, Fenfang Zeng. (2006) Isolation of Human Bone Marrow Mesenchymal Stem Cells by a Novel Monoclonal Antibody, ZUC3. Blood. 108(11): 2562. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Yi Luo, He Huang*, Zhen Cai, Yamin Tan, Xiaoyan Han. (2006) A Fludarabine-Based Non-Myeloablative Conditioning Regimen in Allogeneic Stem Cell Transplantation from Related and Unrelated Donors in Chronic Myeloid Leukemia. Blood. 108 (11): 5372. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Guoqing Wei, Maofang Lin, Zhen Cai, He Huang*. (2006) Human Cytomegalovirus Can Induce Alteration of β-Actin mRNA and Microfilaments as Well as Induce Apoptosis in Mesenchymal Stem Cells. Blood. 108(11): 4261. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Wan-Zhuo Xie, Mao-Fang Lin, He Huang*, Zhen Cai. (2006) Proteinase-Activated Receptor 1 Expression in Human Leukemia HL-60 Cells and Its Significance. Blood. 108(11): 4484. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Jingsong He, Xiujin Ye, Weiyan Zheng, Wenjun Wu, Maofang Lin, He Huang*. (2006) Candida tropicalis Arthritis of the Knee in a Patient with Acute Monocytic Leukemia. Blood. 108(11): 3867. (Meeting Abstract) (48th the American Society Hematology Annual Meeting)

Xiaoli Zhu, He Huang*. (2005) Effects of Apoptosis in Human Activated Peripheral T-Lymphocytes by Immunosuppressive Drugs. Blood. 106 (11):5219. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Guoqing Wei, Maofang Lin, Guangsheng Zhao, He Huang*. (2005) Human Cytomegalovirus Can Infect Multiple Myeloma Cells and Protect the Cells from Apoptosis. Blood. 106 (11): 5059. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Yi Luo, He Huang*, Zhen Cai, Maofang Lin. (2005) Tandem Autotransplants' Peripheral Blood Stem Cells Following Sequent High-Dose CHEOP Chemotherapy for Aggressive Lymphoma. Blood. 106 (11):5510. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Zhen Cai, Xiaoyan Han, He Huang*, Wanzhuo Xie, Weiyan Zheng, Maofang Lin. (2005) Clinical Investigation of G-CSF-Priming Regimen in Treatment of Relapsing, Refractory and Senile Acute Myeloid Leukemia. Blood. 106 (11): 4620. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

He Huang*, Lihong Shou, Yi Luo, Jimin Shi, Xiaoli Zhu, Zhen Cai, Maofang Lin. (2005) The Effect of Dipeptiven in Patients after Allogenic Hematologic Stem Cell Transplantation. Blood. 106 (11): 5371. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Jianping Lan, He Huang*, Yuanyuan Zhu, Jian Yu, Jie. (2005) Chromosomal Instability Induced by Overexpression of Telomere Repeats Binding Factor 1. Blood, 106 (11):4398. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Jie Sun, He Huang*, Yuanyuan Zhu, Jianping Lan, Xiaoyu Lai. (2005) Study on Expression of Telomerase Inhibitor Pinx1 in Leukemia Cells and Its Correlation with Telomerase Activity. Blood. 106 (11): 4375. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Xiaoyu Lai, He Huang*, Yi Luo, Zhixiong Liao, Jiangen Shen. (2005) New Monoclonal Antibodies Reactive with Human Bone Marrow-Derived Mesenchymal Stem Cells. Blood. 106 (11): 4318. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Wan-Zhuo Xie, He Huang*, Zhen Cai, Mao-Fang, Lin Frank Gieseler. (2005) Proteinase-Activated Receptor 1, 3 Expression in Primary Human Carcinoma Cells. Blood. 106 (11): 4113. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Haibo Mou, Maofang Lin, He Huang*. (2005) Transforming Growth Factor-β1 Inhibits the Maturation of Dendritic Cells Via Toll-Like Receptor 4 Signaling Pathway. Blood. 106 (11): 3861. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Zhen Cai, Gaofeng Zhen, Huang He*, Li Li, Wanzuo Xie, Jimin Shi, Jingsong He, Maofang Lin. (2005) Effect of Plasma Exchange on Acute Graft Versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 106 (11): 5246. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Lin MF, Jiang YL, Huang H*. (2005) Synergic effects of immunosuppressive agents on T lymphocyte function and cytokine expression pattern. Blood. 106 (11): 5213. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Cai Z, Xue XK, Sun WJ, Yao HP, Huang H*. (2005) Rerovirus mediated HSV-TK gene transfer can influence the function of human T-lymphocyte. Blood. 106 (11): 5245. (Meeting Abstract) (47th the American Society Hematology Annual Meeting)

Yi Luo, He Huang*, Bin Liang, Qin Yu. (2004) Influence of Cryopreservation on the Biological Characteristics of Adult Bone Marrow Mesenchymal Stem Cells. Blood. 104 (11): 4254. (Meeting Abstract) (46th the American Society Hematology Annual Meeting)

Guoqing Wei, Maofang Lin, He Huang*, Zhen Cai. (2004) NF-κB Inhibitor Pyrrolidinedithiocarbamate Can Increase the Infection and Activation of Cytomegalovirus in Mesenchymal Stem Cells. Blood. 104(11): 4948. (Meeting Abstract) (46th the American Society Hematology Annual Meeting)

Guoqing Wei, Maofang Lin, He Huang*, Zhen Cai. (2004) Human Cytomegalovirus Can Activate and Induce Apoptosis in Mesenchymal Stem Cells. Blood. 104 (11): 4974. (Meeting Abstract) (46th the American Society Hematology Annual Meeting)

Jianping Lan, He Huang*, Yuanyuan Zhu, Jie Sun. (2004) The Fluctuation of Telomere Repeat Binding Factor 1 during Cell Cycle and Its Localization in Telomerase-Positive and Negative Cells. Blood. 104 (11): 4326. (Meeting Abstract) (46th the American Society Hematology Annual Meeting)

Haibo Mou, Maofang Lin, Hong Cen, He Huang*, Zhen Cai. Prevention of Murine Acute Graft-Versus-Host Disease by Recipient-Derived TGFβ1-Treated Dendritic cells. Blood. 104 (11): 838A. (Meeting Abstract) (46th the American Society Hematology Annual Meeting)

Huang H*, Cai Z, Lin MF, Xie WZ, Li L, Luo Y, He JS, Zheng WY, Zhang J, Ye XJ, Liang B. (2004) Mycophenolate mofetil, cyclosporine and methotrexate as graft-versus-host disease prevention regimen in recipients of unrelated bone marrow transplantation. Bone Marrow Transplant. 33:S182-S183.(Meeting Abstract) (30th Annual Meeting of the European Group for Blood and Marrow Transplantation )